Diabetic patients can do as well on peritoneal dialysis as nondiabetic patients

Blood Purification

Volumn 23, Issue 4, 2005, Pages 330-337

  Tang, Wen ^a   Cheng, Li Tao ^a   Wang, Tao ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Diabetics; Malnutrition; Peritoneal dialysis; Volume control

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; IMPEDANCE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EXTRACELLULAR FLUID; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PREVALENCE; UREMIA; URINATION;

EID: 24944539871     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087771     Document Type: Article

References (51)

1. Locatelli F, Pozzoni P, Del Vecchio L: Renal replacement therapy in patients with diabetes and end-stage renal disease. J Am Soc Nephrol 2004;15(suppl 1):S25-S29.
2. Schwenger V, Zeier M, Ritz E: How can the poor outcomes for diabetic dialysis patients be improved? Semin Dial 2004;17:186-187.
3. Kaur J, Singh P, Sowers JR: Diabetes and cardiovascular diseases. Am J Ther 2002;9:510-515.
4. McMurray SD: The challenges of diabetes care in the dialysis unit. Semin Dial 2003;16:197-198.
5. Abu-Alfa AK, Burkart J, Piraino B, Pulliam J, Mujais S: Approach to fluid management in peritoneal dialysis: a practical algorithm. Kidney Int 2002;81(suppl):S8-S16.
6. Wang T, Heimburger O, Waniewski J, Bergstrom J, Lindholm B: Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 1998;13:1242-1249.
7. Johnson DW, Mudge DW, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Hollett P: Predictors of decline of residual renal function in new peritoneal dialysis patients. Perit Dial Int 2003;23:276-283.
8. Tzamaloukas AH, Murata GH, Malhotra D: Renal clearances in continuous ambulatory peritoneal dialysis: differences between diabetic and non-diabetic subjects. Int J Artif Organs 2001;24:203-207.
9. Bell DS: Diabetic cardiomyopathy. Diabetes Care 2003;26:2949-2951.
10. Bell DS: Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 2003;26:2433-2441.
11. Lok CE, Oliver MJ, Rothwell DM, Hux JE: The growing volume of diabetes-related dialysis: a population based study. Nephrol Dial Transplant 2004;19:3098-3103.
12. Wang T, Lindholm B: Beyond CANUSA. DOQI, ADEMEX: what's next? Adequacy of Peritoneal Dialysis in Mexico. Canada-USA. Dialysis Outcomes Quality Initiative. Perit Dial Int 2002;22:555-562.
13. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-3167.
14. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, Bosselmann HP, Heimburger O, Simonsen O, Davenport A, Tranaeus A, Divino Filho JC: Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003;14:2338-2344.
15. Konings CJ, Kooman JP, Schonck M, Struijk DG, Gladziwa U, Hoorntje SJ, van der Wall Bake AW, van der Sande FM, Leunissen KM: Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study. Nephrol Dial Transplant 2003;18:797-803.
16. Nolph KD, Moore HL, Prowant B, Meyer M, Twardowski ZJ, Khanna R, Ponferrada L, Keshaviah P: Cross-sectional assessment of weekly urea and creatinine clearance and indices of nutrition in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1993;13:178-183.
17. Watson P, Watson I, Batt R: Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980;33:27-39.
18. Lee DS, Donovan L, Austin PC, Gong Y, Liu PP, Rouleau JL, Tu JV: Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care 2005;43:182-188.
19. Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE: Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 2001;12:1927-1936.
20. Waitzberg DL, Correia MI: Nutritional assessment in the hospitalized patient. Curr Opin Clin Nutr Metab Care 2003;6:531-538.
21. Kopple JD: National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2001; 37:S66-S70.
22. Wang AY, Wang M, Woo J, Lam CW, Lui SF, Li PK, Sanderson JE: Inflammation, residual renal function, and cardiac hypertrophy are interrelated and combine adversely to enhanced mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 2004;15:2186-2194.
23. Fried L, Bernardini J, Piraino B: Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis 2001;37:337-342.
24. van Olden RW, Krediet RT, Struijk DG, Arisz L: Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1996;7:745-750.
25. Rocco MV, Jordan JR, Burkart JM: 24-hour dialysate collection for determination of peritoneal membrane transport characteristics: longitudinal follow-up data for the dialysis adequacy and transport test (DATT). Perit Dial Int 1996;16:590-593.
26. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK: Dialysis adequacy and transport test for characterization of peritoneal transport type in Chinese peritoneal dialysis patients receiving three daily exchanges. Am J Kidney Dis 2002; 39:1287-1299.
27. Rychlik I, Miltenberger-Miltenyi G, Ritz E: The drama of the continuous increase in end-stage renal failure in patients with type II diabetes mellitus. Nephrol Dial Transplant 1998;13(suppl 8):6-10.
28. Chua DY, Bakris GL: Diabetes and chronic kidney disease: tragedy and challenge. Blood Purif 2004;22:130-135.
29. Langford MC: Type 2 diabetes and chronic systolic heart failure: clinical implications. J Cardiovasc Nurs 2004;19:S35-S44.
30. Viglino G, Cancarini GC, Catizone L, Cocchi R, De Vecchi A, Lupo A, Salomone M, Segoloni GP, Giangrande A: Ten years experience of CAPD in diabetics: comparison of results with non-diabetics. Italian Cooperative Peritoneal Dialysis Study Group. Nephrol Dial Transplant 1994;9:1443-1448.
31. Passadakis P, Oreopoulos D: Peritoneal dialysis in diabetic patients. Adv Ren Replace Ther 2001;8:22-41.
32. Chantrel F, Enache I, Bouiller M, Kolb I, Kunz K, Petitjean P, Moulin B, Hannedouche T: Abysmal prognosis of patients with type 2 diabetes entering dialysis. Nephrol Dial Transplant 1999;14:129-136.
33. Hu FB, Stampfer MJ: Is type 2 diabetes mellitus a vascular condition? Arterioscler Thromb Vasc Biol 2003;23:1715-1716.
34. Dumler F: Hypoalbuminemia is a marker of overhydration in chronic maintenance patients on dialysis. ASAIO J 2003;49:282-286.
35. Cox-Reijven PL, Kooman JP, Soeters PB, van der Sande FM, Leunissen KM: Role of bioimpedance spectroscopy in assessment of body water compartments in hemodialysis patients. Am J Kidney Dis 2001;38:832-838.
36. Zhu F, Schneditz D, Wang E, Martin K, Morris AT, Levin NW: Validation of changes in extracellular volume measured during hemodialysis using a segmental bioimpedance technique. ASAIO J 1998;44:M541-M545.
37. Katzarski K, Charra B, Laurent G, Lopot F, Divino-Filho JC, Nisell J, Bergstrom J: Multi-frequency bioimpedance in assessment of dry weight in haemodialysis. Nephrol Dial Transplant 1996;11(suppl 2):20-23.
38. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998;9:S16-S23.
39. Holtta T, Happonen JM, Ronnholm K, Fyhrquist F, Holmberg C: Hypertension, cardiac state, and the role of volume overload during peritoneal dialysis. Pediatr Nephrol 2001;16:324-331.
40. Lameire N, Van Biesen W: Importance of blood pressure and volume control in peritoneal dialysis patients. Perit Dial Int 2001;21:206-211.
41. Konings CJ, Kooman JP, Schonck M, Gladziwa IJ, Wirtz J, van den Wall Bake AW, Gerlag PG, Hoorntje SJ, Wolters J, van der Sande FM, Leunissen KM: Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study. Kidney Int 2003;63:1556-1563.
42. Wang AY, Sea MM, Ip R, Law MC, Chow KM, Lui SF, Li PK, Woo J: Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2001;12:2450-2457.
43. Lopez-Menchero R, Miguel A, Garcia-Ramon R, Perez-Contreras J, Girbes V: Importance of residual renal function in continuous ambulatory peritoneal dialysis: its influence on different parameters of renal replacement treatment. Nephron 1999;83:219-225.
44. Caravaca F, Arrobas M, Dominguez C: Influence of residual renal function on dietary protein and caloric intake in patients on incremental peritoneal dialysis. Perit Dial Int 1999;19:350-356.
45. Young GA, Kopple JD, Lindholm B, Vonesh EF, De Vecchi A, Scalamogria A, Castelnova C, Oreopoulos DG, Anderson GH, Bergstrom J: Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis 1991;17:462-471.
46. Jager KJ, Merkus MP, Huisman RM, Boeschoten EW, Dekker FW, Korevaar JC, Tijssen JG, Krediet RT: Nutritional status over time in hemodialysis and peritoneal dialysis. J Am Soc Nephrol 2001;12:1272-1279.
47. Cheng LT, Tang W, Wang T: Strong association between volume status and nutritional status in peritoneal dialysis patients. Am J Kidney Dis 2005;45:891-902.
48. Wang AY, Sanderson J, Sea MM, Wang M, Lam CW, Li PK, Lui SF, Woo J: Important factors other than dialysis adequacy associated with inadequate dietary protein and energy intakes in patients receiving maintenance peritoneal dialysis. Am J Clin Nutr 2003;77:834-841.
49. Aguilera A, Codoceo R, Seigas R, Garcia P, Picornell M, Diaz C, Sanchez C, Bajo MA: Anorexigen (TNF-alpha, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: their relationship with nutritional parameters. Nephrol Dial Transplant 1998;13:1476-1483.
50. Fantino M, Wieteska L: Evidence for a direct central anorectic effect of tumor-necrosis-factor-alpha in the rat. Physiol Behav 1993;53:477-483.
51. Jones CH, Wells L, Stoves J, Farquhar F, Woodrow G: Can a reduction in extracellular fluid volume result in increased serum albumin in peritoneal dialysis patients? Am J Kidney Dis 2002;39:872-875.